Biocogniv Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Investors
  • 18

Biocogniv General Information

Description

Developer of an AI-powered diagnostic platform intended to serve emergency departments. The company's technology predicts sepsis-related in-hospital mortality and intensive care unit admission at emergency department presentations as well as seamlessly integrates with electronic health record workflows, enabling the medical sector to develop accurate and non-invasive diagnostic methods easily and quickly.

Contact Information

Website
www.biocogniv.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 50 Lakeside Avenue
  • Suite 851
  • Burlington, VT 05401
  • United States
+1 (802)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 50 Lakeside Avenue
  • Suite 851
  • Burlington, VT 05401
  • United States
+1 (802)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocogniv Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 19-Mar-2026 Announced Generating Revenue
4. Seed Round 03-Oct-2023 Completed Generating Revenue
3. Grant 01-Sep-2020 Completed Generating Revenue
2. Grant 01-Sep-2020 $510K $150K Completed Generating Revenue
1. Accelerator/Incubator 26-Aug-2020 $150K $150K Completed Generating Revenue
To view Biocogniv’s complete valuation and funding history, request access »

Biocogniv Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-5
Seed-4
Seed-3
Seed-2 1,068,679 $0.000010 $0.14 $0.14 1x $0.14 5.48%
Seed-1 3,171,159 $0.000010 $1.58 $1.58 1x $1.58 12.85%
To view Biocogniv’s complete cap table history, request access »

Biocogniv Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Biocogniv Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12346829-B2 Dynamic model selection and rule based data interpretation Active 28-Jul-2021
US-20230030064-A1 Dynamic model selection and rule based data interpretation Active 28-Jul-2021
US-20230290457-A1 Artificial intelligence medical device Inactive 23-Mar-2020
US-11676722-B1 Method of early detection, risk stratification, and outcomes prediction of a medical disease or condition with machine learning and routinely taken patient data Active 23-Mar-2020
US-20250166758-A1 Method of early detection, risk stratification, and outcomes prediction of a medical disease or condition with machine learning and routinely taken patient data Pending 23-Mar-2020 G16H10/60
To view Biocogniv’s complete patent history, request access »

Biocogniv Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocogniv Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
1984 Ventures Venture Capital Minority
AltaIR Capital Venture Capital Minority
Breyer Capital Venture Capital Minority
Dudley Fund Venture Capital Minority
Inflect Capital Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Biocogniv FAQs

  • When was Biocogniv founded?

    Biocogniv was founded in 2019.

  • Where is Biocogniv headquartered?

    Biocogniv is headquartered in Burlington, VT.

  • What is the size of Biocogniv?

    Biocogniv has 4 total employees.

  • What industry is Biocogniv in?

    Biocogniv’s primary industry is Decision/Risk Analysis.

  • Is Biocogniv a private or public company?

    Biocogniv is a Private company.

  • What is Biocogniv’s current revenue?

    The current revenue for Biocogniv is .

  • How much funding has Biocogniv raised over time?

    Biocogniv has raised $10.9M.

  • Who are Biocogniv’s investors?

    1984 Ventures, AltaIR Capital, Breyer Capital, Dudley Fund, and Inflect Capital are 5 of 18 investors who have invested in Biocogniv.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process